South Korea Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2026-2034
South Korea vaccine market size reached USD 1,185.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,648.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.74% during 2026-2034. The ongoing government commitment to immunization programs, increasing investment in research and development (R&D), rising public health awareness about the importance of vaccines, changing demographic factors, and the growing government support for vaccine exports represent some of the key factors driving the market.
Vaccines refer to biological preparations that provide active acquired immunity to a particular infectious disease. They contain various agents resembling a disease-causing microorganism and are often made from weakened or killed forms of the microbe, its toxins, or its surface proteins. Vaccines are available in various types, including live attenuated, inactivated, subunit, toxoid, conjugate, deoxyribonucleic acid (DNA), and recombinant vector vaccines. They are characterized by their safety, specificity, ability to elicit an immune response, and stability. Vaccines are developed using various materials, such as antigens, adjuvants, preservatives, and stabilizers. Their manufacturing process involves antigen discovery, growth of the antigen in culture, purification, and combination with adjuvants and stabilizers. Vaccines are widely used for the prevention of various diseases like measles, polio, influenza, human papillomavirus infection (HPV), and coronavirus (COVID-19). They aid in reducing the incidence of infectious diseases, lowering healthcare costs, and improving life expectancy. In addition to this, vaccines provide several advantages, such as herd immunity, eradication of diseases, minimization of disease-related complications, and promoting long-term health outcomes.
SOUTH KOREA VACCINE MARKET TRENDS:
The increasing government commitment to immunization programs represents one of the key factors propelling the market growth. Additionally, the increasing investment in research and development (R&D) by biopharmaceutical companies, propelling the innovation of new vaccines, is catalyzing the market growth. Besides this, the rising public health awareness about the importance of vaccinations, leading to increased uptake, is supporting the market growth. Furthermore, South Korea’s advanced biotechnology sector, which provides a robust foundation for vaccine development, is fueling the market growth. In addition, the country’s strategic partnerships with global vaccine manufacturers, which enhance the domestic vaccine supply chain, are boosting the market growth. Apart from this, the changing demographic factors, such as the rising geriatric population, which requires vaccines for age-related diseases, are catalyzing the market growth. Moreover, the increasing government support for vaccine exports, which has strengthened South Korea’s position in the global landscape, is acting as another growth-inducing factor. Along with this, the implementation of mass immunization campaigns against seasonal flu and other communicable diseases is contributing to the market growth. In line with this, recent advancements in vaccine technology, such as viral vector vaccines, are supporting the market growth. Additionally, the growing travel and tourism sector, which requires travel-related vaccinations, is stimulating the market growth. Furthermore, the organization of international events in South Korea, promoting the need for vaccines as a public health measure, is positively influencing the market growth. Besides this, the increasing collaborations between academic institutions and industry to promote the rapid development of vaccine candidates are strengthening the market growth across the country.
SOUTH KOREA VACCINE MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on product type, treatment type, technology, route of administration, patient type, indication, distribution channel, and end user.
Product Type Insights:
Treatment Type Insights:
Technology Insights:
Route of Administration Insights:
Patient Type Insights:
Indication Insights:
Distribution Channel Insights:
End User Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea vaccine market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea vaccine market on the basis of product type?
What is the breakup of the South Korea vaccine market on the basis of treatment type?
What is the breakup of the South Korea vaccine market on the basis of technology?
What is the breakup of the South Korea vaccine market on the basis of route of administration?
What is the breakup of the South Korea vaccine market on the basis of patient type?
What is the breakup of the South Korea vaccine market on the basis of indication?
What is the breakup of the South Korea vaccine market on the basis of distribution channel?
What is the breakup of the South Korea vaccine market on the basis of end user?
What are the various stages in the value chain of the South Korea vaccine market?
What are the key driving factors and challenges in the South Korea vaccine?
What is the structure of the South Korea vaccine market and who are the key players?
What is the degree of competition in the South Korea vaccine market?
Vaccines refer to biological preparations that provide active acquired immunity to a particular infectious disease. They contain various agents resembling a disease-causing microorganism and are often made from weakened or killed forms of the microbe, its toxins, or its surface proteins. Vaccines are available in various types, including live attenuated, inactivated, subunit, toxoid, conjugate, deoxyribonucleic acid (DNA), and recombinant vector vaccines. They are characterized by their safety, specificity, ability to elicit an immune response, and stability. Vaccines are developed using various materials, such as antigens, adjuvants, preservatives, and stabilizers. Their manufacturing process involves antigen discovery, growth of the antigen in culture, purification, and combination with adjuvants and stabilizers. Vaccines are widely used for the prevention of various diseases like measles, polio, influenza, human papillomavirus infection (HPV), and coronavirus (COVID-19). They aid in reducing the incidence of infectious diseases, lowering healthcare costs, and improving life expectancy. In addition to this, vaccines provide several advantages, such as herd immunity, eradication of diseases, minimization of disease-related complications, and promoting long-term health outcomes.
SOUTH KOREA VACCINE MARKET TRENDS:
The increasing government commitment to immunization programs represents one of the key factors propelling the market growth. Additionally, the increasing investment in research and development (R&D) by biopharmaceutical companies, propelling the innovation of new vaccines, is catalyzing the market growth. Besides this, the rising public health awareness about the importance of vaccinations, leading to increased uptake, is supporting the market growth. Furthermore, South Korea’s advanced biotechnology sector, which provides a robust foundation for vaccine development, is fueling the market growth. In addition, the country’s strategic partnerships with global vaccine manufacturers, which enhance the domestic vaccine supply chain, are boosting the market growth. Apart from this, the changing demographic factors, such as the rising geriatric population, which requires vaccines for age-related diseases, are catalyzing the market growth. Moreover, the increasing government support for vaccine exports, which has strengthened South Korea’s position in the global landscape, is acting as another growth-inducing factor. Along with this, the implementation of mass immunization campaigns against seasonal flu and other communicable diseases is contributing to the market growth. In line with this, recent advancements in vaccine technology, such as viral vector vaccines, are supporting the market growth. Additionally, the growing travel and tourism sector, which requires travel-related vaccinations, is stimulating the market growth. Furthermore, the organization of international events in South Korea, promoting the need for vaccines as a public health measure, is positively influencing the market growth. Besides this, the increasing collaborations between academic institutions and industry to promote the rapid development of vaccine candidates are strengthening the market growth across the country.
SOUTH KOREA VACCINE MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2026-2034. Our report has categorized the market based on product type, treatment type, technology, route of administration, patient type, indication, distribution channel, and end user.
Product Type Insights:
- Multivalent Vaccine
- Monovalent Vaccine
Treatment Type Insights:
- Preventive Vaccine
- Therapeutic Vaccine
Technology Insights:
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Others
Route of Administration Insights:
- Intramuscular and Subcutaneous Administration
- Oral Administration
- Others
Patient Type Insights:
- Pediatric
- Adult
Indication Insights:
- Bacterial Diseases
- Meningococcal Disease
- Pneumococcal Disease
- Diphtheria/Tetanus/Pertussis (DPT)
- Tuberculosis
- Haemophilus Influenzae (Hib)
- Typhoid
- Others
- Viral Diseases
- Hepatitis
- Influenza
- Human Papillomavirus (HPV)
- Measles/Mumps/Rubella (MMR)
- Rotavirus
- Herpes Zoster
- Varicella
- Japanese Encephalitis
- Rubella
- Polio
- Rabies
- Dengue
- Others
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Institutional Sales
End User Insights:
- Hospitals
- Clinics
- Vaccination Centers
- Academic and Research Institutes
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea vaccine market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea vaccine market on the basis of product type?
What is the breakup of the South Korea vaccine market on the basis of treatment type?
What is the breakup of the South Korea vaccine market on the basis of technology?
What is the breakup of the South Korea vaccine market on the basis of route of administration?
What is the breakup of the South Korea vaccine market on the basis of patient type?
What is the breakup of the South Korea vaccine market on the basis of indication?
What is the breakup of the South Korea vaccine market on the basis of distribution channel?
What is the breakup of the South Korea vaccine market on the basis of end user?
What are the various stages in the value chain of the South Korea vaccine market?
What are the key driving factors and challenges in the South Korea vaccine?
What is the structure of the South Korea vaccine market and who are the key players?
What is the degree of competition in the South Korea vaccine market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA VACCINE MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA VACCINE MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA VACCINE MARKET - BREAKUP BY PRODUCT TYPE
6.1 Multivalent Vaccine
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Monovalent Vaccine
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
7 SOUTH KOREA VACCINE MARKET - BREAKUP BY TREATMENT TYPE
7.1 Preventive Vaccine
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Therapeutic Vaccine
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
8 SOUTH KOREA VACCINE MARKET - BREAKUP BY TECHNOLOGY
8.1 Conjugate Vaccines
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Inactivated and Subunit Vaccines
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Recombinant Vaccines
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Toxoid Vaccines
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Forecast (2026-2034)
8.6 Others
8.6.1 Historical and Current Market Trends (2020-2025)
8.6.2 Market Forecast (2026-2034)
9 SOUTH KOREA VACCINE MARKET - BREAKUP BY ROUTE OF ADMINISTRATION
9.1 Intramuscular and Subcutaneous Administration
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Oral Administration
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Others
9.3.1 Historical and Current Market Trends (2020-2025)
9.3.2 Market Forecast (2026-2034)
10 SOUTH KOREA VACCINE MARKET - BREAKUP BY PATIENT TYPE
10.1 Pediatric
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Forecast (2026-2034)
10.2 Adult
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Forecast (2026-2034)
11 SOUTH KOREA VACCINE MARKET - BREAKUP BY INDICATION
11.1 Bacterial Diseases
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2020-2025)
11.1.3 Market Segmentation
11.1.3.1 Meningococcal Disease
11.1.3.2 Pneumococcal Disease
11.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
11.1.3.4 Tuberculosis
11.1.3.5 Haemophilus Influenzae (Hib)
11.1.3.6 Typhoid
11.1.3.7 Others
11.1.4 Market Forecast (2026-2034)
11.2 Viral Diseases
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2020-2025)
11.2.3 Market Segmentation
11.2.3.1 Hepatitis
11.2.3.2 Influenza
11.2.3.3 Human Papillomavirus (HPV)
11.2.3.4 Measles/Mumps/Rubella (MMR)
11.2.3.5 Rotavirus
11.2.3.6 Herpes Zoster
11.2.3.7 Varicella
11.2.3.8 Japanese Encephalitis
11.2.3.9 Rubella
11.2.3.10 Polio
11.2.3.11 Rabies
11.2.3.12 Dengue
11.2.3.13 Others
11.2.4 Market Forecast (2026-2034)
12 SOUTH KOREA VACCINE MARKET - BREAKUP BY DISTRIBUTION CHANNEL
12.1 Hospital Pharmacies
12.1.1 Overview
12.1.2 Historical and Current Market Trends (2020-2025)
12.1.3 Market Forecast (2026-2034)
12.2 Retail Pharmacies
12.2.1 Overview
12.2.2 Historical and Current Market Trends (2020-2025)
12.2.3 Market Forecast (2026-2034)
12.3 Institutional Sale
12.3.1 Overview
12.3.2 Historical and Current Market Trends (2020-2025)
12.3.3 Market Forecast (2026-2034)
12.4 Others
12.4.1 Historical and Current Market Trends (2020-2025)
12.4.2 Market Forecast (2026-2034)
13 SOUTH KOREA VACCINE MARKET - BREAKUP BY END USER
13.1 Hospitals
13.1.1 Overview
13.1.2 Historical and Current Market Trends (2020-2025)
13.1.3 Market Forecast (2026-2034)
13.2 Clinics
13.2.1 Overview
13.2.2 Historical and Current Market Trends (2020-2025)
13.2.3 Market Forecast (2026-2034)
13.3 Vaccination Centers
13.3.1 Overview
13.3.2 Historical and Current Market Trends (2020-2025)
13.3.3 Market Forecast (2026-2034)
13.4 Academic and Research Institutes
13.4.1 Overview
13.4.2 Historical and Current Market Trends (2020-2025)
13.4.3 Market Forecast (2026-2034)
13.5 Others
13.5.1 Historical and Current Market Trends (2020-2025)
13.5.2 Market Forecast (2026-2034)
14 SOUTH KOREA VACCINE MARKET – BREAKUP BY REGION
14.1 Seoul Capital Area
14.1.1 Overview
14.1.2 Historical and Current Market Trends (2020-2025)
14.1.3 Market Breakup by Product Type
14.1.4 Market Breakup by Treatment Type
14.1.5 Market Breakup by Technology
14.1.6 Market Breakup by Route of Administration
14.1.7 Market Breakup by Patient Type
14.1.8 Market Breakup by Indication
14.1.9 Market Breakup by Distribution Channel
14.1.10 Market Breakup by End User
14.1.11 Key Players
14.1.12 Market Forecast (2026-2034)
14.2 Yeongnam (Southeastern Region)
14.2.1 Overview
14.2.2 Historical and Current Market Trends (2020-2025)
14.2.3 Market Breakup by Product Type
14.2.4 Market Breakup by Treatment Type
14.2.5 Market Breakup by Technology
14.2.6 Market Breakup by Route of Administration
14.2.7 Market Breakup by Patient Type
14.2.8 Market Breakup by Indication
14.2.9 Market Breakup by Distribution Channel
14.2.10 Market Breakup by End User
14.2.11 Key Players
14.2.12 Market Forecast (2026-2034)
14.3 Honam (Southwestern Region)
14.3.1 Overview
14.3.2 Historical and Current Market Trends (2020-2025)
14.3.3 Market Breakup by Product Type
14.3.4 Market Breakup by Treatment Type
14.3.5 Market Breakup by Technology
14.3.6 Market Breakup by Route of Administration
14.3.7 Market Breakup by Patient Type
14.3.8 Market Breakup by Indication
14.3.9 Market Breakup by Distribution Channel
14.3.10 Market Breakup by End User
14.3.11 Key Players
14.3.12 Market Forecast (2026-2034)
14.4 Hoseo (Central Region)
14.4.1 Overview
14.4.2 Historical and Current Market Trends (2020-2025)
14.4.3 Market Breakup by Product Type
14.4.4 Market Breakup by Treatment Type
14.4.5 Market Breakup by Technology
14.4.6 Market Breakup by Route of Administration
14.4.7 Market Breakup by Patient Type
14.4.8 Market Breakup by Indication
14.4.9 Market Breakup by Distribution Channel
14.4.10 Market Breakup by End User
14.4.11 Key Players
14.4.12 Market Forecast (2026-2034)
14.5 Others
14.5.1 Historical and Current Market Trends (2020-2025)
14.5.2 Market Forecast (2026-2034)
15 SOUTH KOREA VACCINE MARKET – COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Market Structure
15.3 Market Player Positioning
15.4 Top Winning Strategies
15.5 Competitive Dashboard
15.6 Company Evaluation Quadrant
16 PROFILES OF KEY PLAYERS
16.1 Company A
16.1.1 Business Overview
16.1.2 Product Portfolio
16.1.3 Business Strategies
16.1.4 SWOT Analysis
16.1.5 Major News and Events
16.2 Company B
16.2.1 Business Overview
16.2.2 Product Portfolio
16.2.3 Business Strategies
16.2.4 SWOT Analysis
16.2.5 Major News and Events
16.3 Company C
16.3.1 Business Overview
16.3.2 Product Portfolio
16.3.3 Business Strategies
16.3.4 SWOT Analysis
16.3.5 Major News and Events
16.4 Company D
16.4.1 Business Overview
16.4.2 Product Portfolio
16.4.3 Business Strategies
16.4.4 SWOT Analysis
16.4.5 Major News and Events
16.5 Company E
16.5.1 Business Overview
16.5.2 Product Portfolio
16.5.3 Business Strategies
16.5.4 SWOT Analysis
16.5.5 Major News and Events
17 SOUTH KOREA VACCINE MARKET - INDUSTRY ANALYSIS
17.1 Drivers, Restraints, and Opportunities
17.1.1 Overview
17.1.2 Drivers
17.1.3 Restraints
17.1.4 Opportunities
17.2 Porters Five Forces Analysis
17.2.1 Overview
17.2.2 Bargaining Power of Buyers
17.2.3 Bargaining Power of Suppliers
17.2.4 Degree of Competition
17.2.5 Threat of New Entrants
17.2.6 Threat of Substitutes
17.3 Value Chain Analysis
18 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA VACCINE MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA VACCINE MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA VACCINE MARKET - BREAKUP BY PRODUCT TYPE
6.1 Multivalent Vaccine
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Monovalent Vaccine
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
7 SOUTH KOREA VACCINE MARKET - BREAKUP BY TREATMENT TYPE
7.1 Preventive Vaccine
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Therapeutic Vaccine
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
8 SOUTH KOREA VACCINE MARKET - BREAKUP BY TECHNOLOGY
8.1 Conjugate Vaccines
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Inactivated and Subunit Vaccines
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Recombinant Vaccines
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Toxoid Vaccines
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Forecast (2026-2034)
8.6 Others
8.6.1 Historical and Current Market Trends (2020-2025)
8.6.2 Market Forecast (2026-2034)
9 SOUTH KOREA VACCINE MARKET - BREAKUP BY ROUTE OF ADMINISTRATION
9.1 Intramuscular and Subcutaneous Administration
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Oral Administration
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Others
9.3.1 Historical and Current Market Trends (2020-2025)
9.3.2 Market Forecast (2026-2034)
10 SOUTH KOREA VACCINE MARKET - BREAKUP BY PATIENT TYPE
10.1 Pediatric
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Forecast (2026-2034)
10.2 Adult
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Forecast (2026-2034)
11 SOUTH KOREA VACCINE MARKET - BREAKUP BY INDICATION
11.1 Bacterial Diseases
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2020-2025)
11.1.3 Market Segmentation
11.1.3.1 Meningococcal Disease
11.1.3.2 Pneumococcal Disease
11.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
11.1.3.4 Tuberculosis
11.1.3.5 Haemophilus Influenzae (Hib)
11.1.3.6 Typhoid
11.1.3.7 Others
11.1.4 Market Forecast (2026-2034)
11.2 Viral Diseases
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2020-2025)
11.2.3 Market Segmentation
11.2.3.1 Hepatitis
11.2.3.2 Influenza
11.2.3.3 Human Papillomavirus (HPV)
11.2.3.4 Measles/Mumps/Rubella (MMR)
11.2.3.5 Rotavirus
11.2.3.6 Herpes Zoster
11.2.3.7 Varicella
11.2.3.8 Japanese Encephalitis
11.2.3.9 Rubella
11.2.3.10 Polio
11.2.3.11 Rabies
11.2.3.12 Dengue
11.2.3.13 Others
11.2.4 Market Forecast (2026-2034)
12 SOUTH KOREA VACCINE MARKET - BREAKUP BY DISTRIBUTION CHANNEL
12.1 Hospital Pharmacies
12.1.1 Overview
12.1.2 Historical and Current Market Trends (2020-2025)
12.1.3 Market Forecast (2026-2034)
12.2 Retail Pharmacies
12.2.1 Overview
12.2.2 Historical and Current Market Trends (2020-2025)
12.2.3 Market Forecast (2026-2034)
12.3 Institutional Sale
12.3.1 Overview
12.3.2 Historical and Current Market Trends (2020-2025)
12.3.3 Market Forecast (2026-2034)
12.4 Others
12.4.1 Historical and Current Market Trends (2020-2025)
12.4.2 Market Forecast (2026-2034)
13 SOUTH KOREA VACCINE MARKET - BREAKUP BY END USER
13.1 Hospitals
13.1.1 Overview
13.1.2 Historical and Current Market Trends (2020-2025)
13.1.3 Market Forecast (2026-2034)
13.2 Clinics
13.2.1 Overview
13.2.2 Historical and Current Market Trends (2020-2025)
13.2.3 Market Forecast (2026-2034)
13.3 Vaccination Centers
13.3.1 Overview
13.3.2 Historical and Current Market Trends (2020-2025)
13.3.3 Market Forecast (2026-2034)
13.4 Academic and Research Institutes
13.4.1 Overview
13.4.2 Historical and Current Market Trends (2020-2025)
13.4.3 Market Forecast (2026-2034)
13.5 Others
13.5.1 Historical and Current Market Trends (2020-2025)
13.5.2 Market Forecast (2026-2034)
14 SOUTH KOREA VACCINE MARKET – BREAKUP BY REGION
14.1 Seoul Capital Area
14.1.1 Overview
14.1.2 Historical and Current Market Trends (2020-2025)
14.1.3 Market Breakup by Product Type
14.1.4 Market Breakup by Treatment Type
14.1.5 Market Breakup by Technology
14.1.6 Market Breakup by Route of Administration
14.1.7 Market Breakup by Patient Type
14.1.8 Market Breakup by Indication
14.1.9 Market Breakup by Distribution Channel
14.1.10 Market Breakup by End User
14.1.11 Key Players
14.1.12 Market Forecast (2026-2034)
14.2 Yeongnam (Southeastern Region)
14.2.1 Overview
14.2.2 Historical and Current Market Trends (2020-2025)
14.2.3 Market Breakup by Product Type
14.2.4 Market Breakup by Treatment Type
14.2.5 Market Breakup by Technology
14.2.6 Market Breakup by Route of Administration
14.2.7 Market Breakup by Patient Type
14.2.8 Market Breakup by Indication
14.2.9 Market Breakup by Distribution Channel
14.2.10 Market Breakup by End User
14.2.11 Key Players
14.2.12 Market Forecast (2026-2034)
14.3 Honam (Southwestern Region)
14.3.1 Overview
14.3.2 Historical and Current Market Trends (2020-2025)
14.3.3 Market Breakup by Product Type
14.3.4 Market Breakup by Treatment Type
14.3.5 Market Breakup by Technology
14.3.6 Market Breakup by Route of Administration
14.3.7 Market Breakup by Patient Type
14.3.8 Market Breakup by Indication
14.3.9 Market Breakup by Distribution Channel
14.3.10 Market Breakup by End User
14.3.11 Key Players
14.3.12 Market Forecast (2026-2034)
14.4 Hoseo (Central Region)
14.4.1 Overview
14.4.2 Historical and Current Market Trends (2020-2025)
14.4.3 Market Breakup by Product Type
14.4.4 Market Breakup by Treatment Type
14.4.5 Market Breakup by Technology
14.4.6 Market Breakup by Route of Administration
14.4.7 Market Breakup by Patient Type
14.4.8 Market Breakup by Indication
14.4.9 Market Breakup by Distribution Channel
14.4.10 Market Breakup by End User
14.4.11 Key Players
14.4.12 Market Forecast (2026-2034)
14.5 Others
14.5.1 Historical and Current Market Trends (2020-2025)
14.5.2 Market Forecast (2026-2034)
15 SOUTH KOREA VACCINE MARKET – COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Market Structure
15.3 Market Player Positioning
15.4 Top Winning Strategies
15.5 Competitive Dashboard
15.6 Company Evaluation Quadrant
16 PROFILES OF KEY PLAYERS
16.1 Company A
16.1.1 Business Overview
16.1.2 Product Portfolio
16.1.3 Business Strategies
16.1.4 SWOT Analysis
16.1.5 Major News and Events
16.2 Company B
16.2.1 Business Overview
16.2.2 Product Portfolio
16.2.3 Business Strategies
16.2.4 SWOT Analysis
16.2.5 Major News and Events
16.3 Company C
16.3.1 Business Overview
16.3.2 Product Portfolio
16.3.3 Business Strategies
16.3.4 SWOT Analysis
16.3.5 Major News and Events
16.4 Company D
16.4.1 Business Overview
16.4.2 Product Portfolio
16.4.3 Business Strategies
16.4.4 SWOT Analysis
16.4.5 Major News and Events
16.5 Company E
16.5.1 Business Overview
16.5.2 Product Portfolio
16.5.3 Business Strategies
16.5.4 SWOT Analysis
16.5.5 Major News and Events
17 SOUTH KOREA VACCINE MARKET - INDUSTRY ANALYSIS
17.1 Drivers, Restraints, and Opportunities
17.1.1 Overview
17.1.2 Drivers
17.1.3 Restraints
17.1.4 Opportunities
17.2 Porters Five Forces Analysis
17.2.1 Overview
17.2.2 Bargaining Power of Buyers
17.2.3 Bargaining Power of Suppliers
17.2.4 Degree of Competition
17.2.5 Threat of New Entrants
17.2.6 Threat of Substitutes
17.3 Value Chain Analysis
18 APPENDIX
